Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (3)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Biesenbach, G.
Right arrow Articles by Zazgornik, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Biesenbach, G.
Right arrow Articles by Zazgornik, J.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nephrology Dialysis Transplantation, Vol 14, Issue 3 655-658, Copyright © 1999 by Oxford University Press

ORIGINAL ARTICLES

Nutritional status in type 2 diabetic patients requiring haemodialysis

G Biesenbach, A Debska-Slizien and J Zazgornik
Second Department of Medicine, General Hospital Linz, Krankenhausstrasse 9, A-4020 Linz, Austria; Department of Nephrology, Gdansk Medical University, Gdansk, Poland; Corresponding author

Background. Type 2 diabetic patients with end-stage renal disease are often overweight (BMI>24) at the start of dialysis therapy. However, there are very few reports in the literature concerning the nutritional status of these patients after prolonged haemodialysis treatment. Therefore, we compared nutritional parameters in type 2 diabetic patients and age-matched non-diabetic patients after at least 18 months of renal replacement therapy with haemodialysis. Methods. In a cross-sectional study, we measured BMI, serum albumin, total protein, serum cholesterol and interdialytic weight gain (IWG), and performed a subjective global assessment (SGA) in 14 patients with type 2 diabetes and 16 non-diabetic patients (aged ⩾50 years, haemodialysis therapy ⩾18 months). Protein intake was estimated using the protein catabolic rate (PCR) and Kt/V was calculated to compare the dose of dialysis. Results. BMI was significantly higher in patients with type 2 diabetes (30±7 vs 24±3, P<0.01). In contrast, the concentration of serum albumin was significantly lower (3180±499 mg/dl vs 3576±431 mg/dl, P<0.05), but six of the diabetic patients had signs of chronic inflammation. All other nutritional parameters did not differ between the two groups. In addition, there were no significant differences in the intake of protein (PCR 0.93±0.19 vs 0.92±0.22) and the dose of dialysis (Kt/V 1.13±0.19 vs 1.2±0.2). Conclusion. After ⩾18 months of haemodialysis therapy, the majority of type 2 diabetic patients (9/14) were still overweight (BMI>24). The nutritional status of diabetic patients was similar to that of age-matched non-diabetic patients on prolonged haemodialysis, but serum albumin levels were significantly lower in diabetics. The lower albumin levels in the diabetic patients may be explained by a state of subclinical chronic inflammation. Keywords: dietary protein intake; haemodialysis; nutritional; type 2 diabetes
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.